O-propanoylcarnitine (internal charge) clinical trials
How each study uses O-propanoylcarnitine (internal charge) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the O-propanoylcarnitine (internal charge) studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Propionyl-L-Carnitine
- 4
Studies by the year they started
8 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2008 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 1
sigma-tau i.f.r. S.p.A. (3) · Lee's Pharmaceutical Limited (3) · Sigma-Tau Research, Inc. (1) · University of Pennsylvania (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test O-propanoylcarnitine (internal charge).
- May 2027Matching Perfusion and Metabolic Activity in HFpEFPhase 2 · University of Pennsylvania
Studies
Open first, then newest update. How each study uses O-propanoylcarnitine (internal charge) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Matching Perfusion and Metabolic Activity in HFpEFRecruitingPhase 2University of PennsylvaniaNCT04913805Written as Potassium Nitrate + Propionyl-L-Carnitine + Nicotinamide RibosideHow we know
- Propionyl-L-Carnitine in Ulcerative ColitisCompletedPhase 2sigma-tau i.f.r. S.p.A.NCT01026857Written as Propionyl-L-CarnitineHow we know
- Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability StudyTerminatedPhase 3sigma-tau i.f.r. S.p.A.NCT01567956Written as Propionyl-L-CarnitineHow we know
- Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative ColitisTerminatedPhase 3sigma-tau i.f.r. S.p.A.NCT01538251Written as Propionyl-L-CarnitineHow we know
- A Single-dose Escalation Safety and PK Study for PLC in Healthy ChineseCompletedPhase 1Lee's Pharmaceutical LimitedNCT02786069Written as Propionyl L-carnitine HydrochlorideHow we know
- PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-dosesCompletedPhase 1Lee's Pharmaceutical LimitedNCT02786043Written as Propionyl-L-Carnitine HydrochlorideHow we know
- A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial DiseasesCompletedPhase 3Lee's Pharmaceutical LimitedNCT00809497Written as Propionyl-L-carnitine TabletsHow we know
- Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)CompletedPhase 3Sigma-Tau Research, Inc.NCT00399919Written as Propionyl-L-CarnitineHow we know
Codes
What other systems call O-propanoylcarnitine (internal charge) · ClinicalTrials.gg INT015983
- Wikidata Q27103933O-propanoylcarnitine (internal charge)One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27103933 | O-propanoylcarnitine (internal charge) | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.